About Collin Todd
Form D filings for CTRL Therapeutics USA in 2024 list Collin Todd as director.
Collin Todd first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Collin Todd in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Collin Todd works with at each company, as listed on that company's latest Form D.
CTRL Therapeutics USA, Inc. · Form D, Sep 27, 2024
DP
Derrell Porter
Chief Executive Officer and director
DN
David O'Neill
Director
SK
Shana Kelley
Executive officer and director